Table 1.
Summary of opioid agonist therapy by provincea.
| Province oversight | Methadone training and exemption | Urine drug screening guidelines | Province-funded methadone (M) or buprenorphine (B) | Patient registry | Patientsb | Physiciansb |
|---|---|---|---|---|---|---|
| BC | ✓ | ✓ | M/B | ✓ | 16,457 (351) | 528 (11) |
| AB | ✓ | ✓ | M/B | >3500 (83) | 50-100 (2) | |
| SK | ✓ | ✓ | M/B | >2000 (176) | <50 (4) | |
| MB | ✓ | ✓ | M | <1000 (77) | <50 (4) | |
| ON | ✓ | ✓ | M/B | >42,000 (305) | 475 (3) | |
| QC | ✓ | ✓ | M/B | >3400 (41) | >230 (3) | |
| NB | ✓ | ✓ | M/B | 1916 (254) | >40 (5) | |
| NS | ✓ | ✓ | M/B | ✓ | >1000 (106) | 29 (3) |
| NF | ✓ | ✓ | M/B | ✓ | >1000 (189) | <10 (2) |
| PE | ✓ | M/B | >200 (137) | >10 (7) |
aData for Nunavut, Northwest Territories, and Yukon are not publically available.
bExpressed as number (with n per 100,000 in parentheses). These numbers represent the authors’ best approximation based on available information at the time of publication.